GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » COGS-to-Revenue

Symbion Health (ASX:SY1) COGS-to-Revenue : 0.70 (As of Jun. 2007)


View and export this data going back to . Start your Free Trial

What is Symbion Health COGS-to-Revenue?

Symbion Health's Cost of Goods Sold for the six months ended in Jun. 2007 was A$2,696.00 Mil. Its Revenue for the six months ended in Jun. 2007 was A$3,826.37 Mil.

Symbion Health's COGS to Revenue for the six months ended in Jun. 2007 was 0.70.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Symbion Health's Gross Margin % for the six months ended in Jun. 2007 was 29.54%.


Symbion Health COGS-to-Revenue Historical Data

The historical data trend for Symbion Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symbion Health COGS-to-Revenue Chart

Symbion Health Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 1.18 1.36 1.37 0.70

Symbion Health Semi-Annual Data
Jun95 Jun96 Jun97 Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 1.18 1.36 1.37 0.70

Symbion Health COGS-to-Revenue Calculation

Symbion Health's COGS to Revenue for the fiscal year that ended in Jun. 2007 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2696 / 3826.369
=0.70

Symbion Health's COGS to Revenue for the quarter that ended in Jun. 2007 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2696 / 3826.369
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Symbion Health  (ASX:SY1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Symbion Health's Gross Margin % for the six months ended in Jun. 2007 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 2696 / 3826.369
=29.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Symbion Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Symbion Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Symbion Health (ASX:SY1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Symbion Group Limited (SYB, formerly Mayne Group Limited) is a healthcare-focused company comprised of 5 divisions: Pathology; Medical Centres; Imaging; Pharmacy Services; and Symbion Consumer.

Symbion Health (ASX:SY1) Headlines

No Headlines